Delivery Order SPE2DB20D3103-SPE2DB25FQ2T5
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,502.89 delivery order on July 21, 2025, for Twinrix vaccine in syringe form, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $11,153.57 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-competitive, firm fixed-price delivery order was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,707.70 to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe format. This is a firm fixed price, competitively awarded contract with no set-aside designation, with a completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,827.32 to AmerisourceBergen Drug Corp for Twinrix vaccine in syringe form. This competitively awarded, firm fixed-price contract was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $47,667.15 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This non-competitive, firm fixed-price delivery order was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,396.10 to AmerisourceBergen Drug Corp for TWINRIX vaccine syringes on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,822.80 for TWINRIX vaccine syringes (1mL, 10-count units) under a firm fixed-price contract. The award, issued on August 1, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive, non-set-aside procurement. This delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order valued at $91,647.30 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This competitively awarded, firm fixed-price contract was issued on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $9,202.68 to AmerisourceBergen Drug Corp for the supply of Twinrix vaccine in syringe format. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 5, 2025, and performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with the DLA. AmerisourceBergen...
- The Defense Logistics Agency awarded a $25,946.28 delivery order to AmerisourceBergen Drug Corp for Twinrix vaccine syringes on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made on a competitive basis without set-aside designation,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ2T5Delivery Order
The Defense Logistics Agency awarded a $107,038.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TWINRIX vaccine in syringe form, with performance at the contractor's Conshohocken, Pennsylvania location. The award was made competitively with no set-aside designation and carries an ultimate completion date of September 15, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support contract enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor headquartered in Pennsylvania that supplies medications, vaccines, medical devices, and healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The company has demonstrated capability to meet federal procurement requirements through multiple competitively awarded contracts with DLA, leveraging its extensive portfolio of brand-name and generic medications alongside specialty medical supplies. This TWINRIX vaccine delivery order reflects the contractor's ongoing role in supporting the Defense Health Agency and broader military healthcare logistics through firm fixed-price transactions under the DLA's pharmaceutical prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $107.0k | 9/12/25 |